• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA - PRINCETON DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL CRANIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA - PRINCETON DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL CRANIAL Back to Search Results
Catalog Number 202050
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Fistula (1862)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
 
Event or Problem Description
This report is 1 of 2 and linked to mfg report number: 1121308-2025-00022: a facility reported that a patient diagnosed with subdural hematoma underwent surgery on (b)(6) 2025.However, in the following days, he developed a fistula that required reoperation.The reoperation was performed to treat the aforementioned complication.The same product references were used in the second surgery, and the patient is in stable condition.
 
Additional Manufacturer Narrative
Updated fields: d4, d9, g3, g6, h2, h3, h4, h6, h11.The duraseal dural sealant system 5ml us box of 5 (202050) was not returned for analysis and the investigation could not confirm the complaint.A dhr review and trending were performed as part of the evaluation.Proper finished good testing was performed prior to release as indicated in the dhr.The root cause is undetermined and was unable to be confirmed in the complaint evaluation.Per the fmea, potential causes of failure include: performance and adhesion barrier.The risk remains acceptable per the risk analysis.No enhancements or improvements were generated for the reported condition.The file will be closed as could not be reliably determined.Should new information become available, the file will be re-opened and the investigation summary will be amended as appropriate.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5
Common Device Name
DURASEAL CRANIAL
Manufacturer (Section D)
INTEGRA - PRINCETON
1100 campus road
1100 campus road
princeton NJ 08540
Manufacturer (Section G)
INTEGRA - PRINCETON
1100 campus road
none
princeton NJ 08540
Manufacturer Contact
vivian nelson
1100 campus drive
princeton, NJ 08540
6099362319
MDR Report Key22385700
Report Number3003418325-2025-00032
Device Sequence Number20577746
Product Code NQR
UDI-Device Identifier10381780000020
UDI-Public10381780000020
Combination Product (Y/N)N
PMA/510(K) Number
P040034
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Distributor
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number202050
Device Lot Number60548845
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/12/2025
Supplement Date Received by Manufacturer07/28/2025
Initial Report FDA Received Date07/02/2025
Supplement Report FDA Received Date08/05/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DURAGEN SUTURABLE ((B)(6)).
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age78 YR
Patient SexMale
-
-